Clinical Trial Update: A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating recombinant botulinum toxin type A (YY001) for injections to treat upper limb spasticity in adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Limb Spasticity

Drugs mentioned

• YY001

Snippet

Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. | Conditions: Upper Limb Spasticity | Phase 3 | Status: RECRUITING